SEC 13F Intelligence

Royal London Asset Management Ltd / ABBV

Royal London Asset Management Ltd’s Abbvie Inc Position

Does Royal London Asset Management Ltd own Abbvie Inc (ABBV)? Yes — 1.35M shares worth $294M (+0.62% of its 13F portfolio) as of Q1 2026, up from 1.31M shares the prior filed quarter.

Position Value
$294M
Q1 2026
Shares
1.35M
% of Portfolio
+0.62%
Quarters Held
30
currently held

Position History ABBV

Reported value by quarter
Q4 ’18: $73MQ4 ’18Q1 ’19: $67MQ2 ’19: $60MQ3 ’19: $62MQ4 ’19: $74MQ4 ’19Q1 ’20: $63MQ2 ’20: $90MQ3 ’20: $82MQ4 ’20: $102MQ4 ’20Q1 ’21: $105MQ2 ’21: $107MQ3 ’21: $100MQ4 ’21: $120MQ4 ’21Q1 ’22: $155MQ2 ’22: $107MQ3 ’22: $122MQ4 ’22: $150MQ4 ’22Q1 ’23: $159MQ2 ’23: $160MQ3 ’23: $191MQ4 ’23: $213MQ4 ’23Q1 ’24: $268MQ2 ’24: $233MQ3 ’24: $271MQ4 ’24: $232MQ4 ’24Q1 ’25: $285MQ2 ’25: $244MQ3 ’25: $302MQ4 ’25: $300MQ4 ’25Q1 ’26: $294Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 20261.35M$294M+0.62%
Q4 20251.31M$300M+0.63%
Q3 20251.31M$302M+0.65%
Q2 20251.31M$244M+0.56%
Q1 20251.36M$285M+0.67%
Q4 20241.31M$232M+0.57%
Q3 20241.37M$271M+0.67%
Q2 20241.36M$233M+0.60%
Q1 20241.47M$268M+0.67%
Q4 20231.37M$213M+0.59%
Q3 20231.28M$191M+0.62%
Q2 20231.19M$160M+0.52%
Q1 2023996.1K$159M+0.64%
Q4 2022926.7K$150M+0.67%
Q3 2022907.1K$122M+0.62%
Q2 2022946.8K$107M+0.45%
Q1 2022958.1K$155M+0.61%
Q4 2021884.5K$120M+0.48%
Q3 2021927.6K$100M+0.43%
Q2 2021946.8K$107M+0.46%
Q1 2021973.4K$105M+0.49%
Q4 2020949.3K$102M+0.53%
Q3 2020946.6K$82M+0.50%
Q2 2020928.1K$90M+0.62%
Q1 2020842.7K$63M+0.51%
Q4 2019832.0K$74M+0.51%
Q3 2019814.9K$62M+0.47%
Q2 2019821.2K$60M+0.56%
Q1 2019827.1K$67M+0.52%
Q4 2018799.7K$73M+0.64%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Royal London Asset Management Ltd’s full portfolio or all institutional holders of ABBV.